From The Editor
-
Pharma's Digital Transformation: Where It's Really At
5/18/2026
Culture is still pharma’s biggest transformation bottleneck – what does it take to move from project thinking to product thinking?
-
How AI Is Changing Clinical Trial Design, Not Just Speed
5/14/2026
The real AI opportunity in clinical trials isn’t efficiency – it’s simulating better studies before enrollment begins.
-
What Is Clinical Trials Day? Why Technology Helps Research Rise
5/13/2026
Clinical Trials Day (May 20) recognizes the legacy of evidence-based medicine and the modern workforce that delivers it, increasingly with help from research technology.
-
DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
5/11/2026
DiMe’s sDHT Adoption Navigator helps clinical teams move from guidance to action, but the real test is whether organizations use it early enough to matter.
-
Digital Endpoints Are Ready. Clinical Development Isn't
5/7/2026
Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
-
Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
5/4/2026
Cleaning data is no longer an afterthought; it’s a continuous, risk-based must-have that protects integrity, ensures compliance, and drives reliable results.
-
Sites Are Building Their Own Tech – SCRS On What That Means
4/30/2026
SCRS’s Jimmy Bechtel on why Bring-Your-Own-Tech is both a protest and a performance differentiator, and what the industry needs to do about it.
-
When The System Breaks, Who Pays? SCRS On Site Tech Gaps
4/27/2026
SCRS CSSO Jimmy Bechtel on why clinical site tech integration is an architecture problem – and who bears the risk when remote systems fail.
-
HTA, Digital Twins, And Building Clinical Tech That Lasts
4/24/2026
ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
4/22/2026
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.